Major General (RET) Kenneth A. Bouldin graduated from the University of Tennessee, Knoxville in 1964 and was commissioned as a 2LT in the Signal Corps.
MG Bouldin served on active duty for 2 years and then served in various United States Army Reserve units, culminating in his assignment as the Commanding General of the 125th US Army Reserve Command. This organization mobilized almost 50% of over 8,000 assigned reservists during Operation Desert Storm. During this time, MG Bouldin served as Commanding General, Fort Campbell, Kentucky during the deployment of the 101st Airborne Division (Air Assault).
MG Bouldin served as National President (1993-94) of the Reserve Officers Association of the United States.
MG Bouldin’s civilian career was in the IT field. He earned membership in the Elite Golden Circle of the 100 Per Cent Club of IBM, established ECONOTECH, an IT staffing firm, and is currently President of KAB Associates, Inc, a venture capital and management consulting firm.
MG Bouldin and his wife, Marianne, established the Hope Fund for SARCOMA Research in partnership with the National Foundation for Cancer Research.
MG Bouldin served on active duty for 2 years and then served in various United States Army Reserve units, culminating in his assignment as the Commanding General of the 125th US Army Reserve Command. This organization mobilized almost 50% of over 8,000 assigned reservists during Operation Desert Storm. During this time, MG Bouldin served as Commanding General, Fort Campbell, Kentucky during the deployment of the 101st Airborne Division (Air Assault).
MG Bouldin served as National President (1993-94) of the Reserve Officers Association of the United States.
MG Bouldin’s civilian career was in the IT field. He earned membership in the Elite Golden Circle of the 100 Per Cent Club of IBM, established ECONOTECH, an IT staffing firm, and is currently President of KAB Associates, Inc, a venture capital and management consulting firm.
MG Bouldin and his wife, Marianne, established the Hope Fund for SARCOMA Research in partnership with the National Foundation for Cancer Research.
